|
CN102459646A
|
|
Markers for detection of gastric cancer
|
|
NZ577012A
|
|
Human zymogen granule protein 16 as a marker for detection of gastric cancer
|
|
NZ562237A
|
|
Proliferation signature and prognosis for gastrointestinal cancer
|
|
NZ555363A
|
|
Prognosis prediction for melanoma cancer
|
|
NZ545243A
|
|
Urine gene expression ratios for detection of cancer
|
|
NZ544432A
|
|
Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
|
|
NZ584549A
|
|
HOXA13 urine marker for detection of bladder cancer
|
|
TW200604528A
|
|
Markers for detection of gastric cancer
|
|
CA2532722A1
|
|
Cystatin sn (cst1) and other markers for detection of gastric cancer
|
|
EP1597383A2
|
|
Variants of cytochrome c and methods of diagnosis of thrombocytopenia
|
|
US2006129034A1
|
|
Medical decision support systems utilizing gene expression and clinical information and method for use
|
|
WO03079286A1
|
|
Medical applications of adaptive learning systems using gene expression data
|
|
NZ537160A
|
|
Medical applications of adaptive learning systems
|
|
NZ547894A
|
|
Medical applications of adaptive learning systems and diagnostic kits
|
